Factors associated with pharmacological and psychotherapy treatments adherence in patients with borderline personality disorder.

borderline personality disorder personality disorders pharmacotherapy psychotherapy treatment outcome

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 28 09 2022
accepted: 22 11 2022
entrez: 30 12 2022
pubmed: 31 12 2022
medline: 31 12 2022
Statut: epublish

Résumé

Borderline personality disorder is a major mental illness characterized by sustained relationship instability, impulsive behavior, and intense affects. Adherence is a complex behavior, from minor refusals to abandonment of treatment, which can be affected by various factors. Therefore, the present study aimed to investigate the factors affecting pharmacological and psychotherapy adherence, patients' attitude toward medication, and assessing medication and treatment adherence in patients with borderline personality disorder referred to an outpatient referral clinic in Tehran, Iran. The study was a cross-sectional study. The files of patients with borderline personality disorder referred to the outpatient clinic of the Tehran Psychiatric Institute were reviewed as the first step. Data were collected using the Drug Attitude Inventory-10 (DAI-10) questionnaire and a questionnaire to determine the attitude of patients toward pharmacological and psychotherapy treatment as well as therapeutic adherence. After collecting data, patients' therapeutic adherence was divided into poor, partial, and good compliance. Ninety-four patients were involved in the study, and fifty-four were women. Findings of DAI showed that 54 (57.4%) participants had negative attitudes toward medication, while 38 (40.4%) participants showed a negative attitude toward psychotherapy treatment. Additionally, the percentage of patients with good psychotherapy adherence (44.7%) was higher than that of patients with good medication adherence (31.9%). The most common reasons for discontinuation of treatment were medication side effects (53.1%), dissatisfaction with the therapist (40.3%), and then fear of medication dependence (40%). Patients with higher education levels and a positive history of hospitalization in a psychiatric ward had better adherence to psychotherapy ( Results of the current study show that attitude toward psychotherapy is more favorable than pharmacotherapy among patients with BPD. The rationale may be that medications are mainly prescribed for comorbid conditions and do not have substantial effects on the BPD symptoms, resulting in low medication adherence.

Sections du résumé

Background UNASSIGNED
Borderline personality disorder is a major mental illness characterized by sustained relationship instability, impulsive behavior, and intense affects. Adherence is a complex behavior, from minor refusals to abandonment of treatment, which can be affected by various factors. Therefore, the present study aimed to investigate the factors affecting pharmacological and psychotherapy adherence, patients' attitude toward medication, and assessing medication and treatment adherence in patients with borderline personality disorder referred to an outpatient referral clinic in Tehran, Iran.
Methods UNASSIGNED
The study was a cross-sectional study. The files of patients with borderline personality disorder referred to the outpatient clinic of the Tehran Psychiatric Institute were reviewed as the first step. Data were collected using the Drug Attitude Inventory-10 (DAI-10) questionnaire and a questionnaire to determine the attitude of patients toward pharmacological and psychotherapy treatment as well as therapeutic adherence. After collecting data, patients' therapeutic adherence was divided into poor, partial, and good compliance.
Results UNASSIGNED
Ninety-four patients were involved in the study, and fifty-four were women. Findings of DAI showed that 54 (57.4%) participants had negative attitudes toward medication, while 38 (40.4%) participants showed a negative attitude toward psychotherapy treatment. Additionally, the percentage of patients with good psychotherapy adherence (44.7%) was higher than that of patients with good medication adherence (31.9%). The most common reasons for discontinuation of treatment were medication side effects (53.1%), dissatisfaction with the therapist (40.3%), and then fear of medication dependence (40%). Patients with higher education levels and a positive history of hospitalization in a psychiatric ward had better adherence to psychotherapy (
Conclusion UNASSIGNED
Results of the current study show that attitude toward psychotherapy is more favorable than pharmacotherapy among patients with BPD. The rationale may be that medications are mainly prescribed for comorbid conditions and do not have substantial effects on the BPD symptoms, resulting in low medication adherence.

Identifiants

pubmed: 36582255
doi: 10.3389/fpsyt.2022.1056050
pmc: PMC9793988
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1056050

Informations de copyright

Copyright © 2022 Mirhaj Mohammadabadi, Mohammadsadeghi, Eftekhar Adrebili, Partovi Kolour, Kashaninasab, Rashedi and Shalbafan.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Psychoactive Drugs. 2022 Jan-Mar;54(1):18-24
pubmed: 33594958
J Caring Sci. 2015 Jun 01;4(2):165-78
pubmed: 26161370
BMC Psychiatry. 2019 Dec 12;19(1):393
pubmed: 31830934
Patient Prefer Adherence. 2017 Aug 30;11:1469-1478
pubmed: 28919719
Psychiatry (Edgmont). 2009 Oct;6(10):16-20
pubmed: 20011575
Am J Psychiatry. 2007 Jun;164(6):929-35
pubmed: 17541053
Curr Opin Psychiatry. 2018 Jan;31(1):69-73
pubmed: 29028643
Int J Psychiatry Clin Pract. 2020 Nov;24(4):380-386
pubmed: 32657194
Schizophr Res. 2017 Jan;179:50-56
pubmed: 27745754
Iran J Psychiatry Behav Sci. 2016 Mar 15;10(2):e2448
pubmed: 27803718
Front Psychiatry. 2020 May 29;11:449
pubmed: 32547429
J Am Coll Health. 2022 May-Jun;70(4):1186-1194
pubmed: 32672512
Neuropsychiatr Dis Treat. 2018 Jun 14;14:1545-1559
pubmed: 29950839
BMC Med Educ. 2021 Sep 22;21(1):502
pubmed: 34551745
CNS Drugs. 2021 Oct;35(10):1053-1067
pubmed: 34495494
Dev Psychopathol. 2012 Feb;24(1):251-65
pubmed: 22293008
Nord J Psychiatry. 2005;59(5):319-24
pubmed: 16757458
Psychiatry Res. 2015 Mar 30;226(1):284-8
pubmed: 25677397
Evid Based Ment Health. 2017 Nov;20(4):123-127
pubmed: 29056609
Healthcare (Basel). 2021 Sep 18;9(9):
pubmed: 34575005

Auteurs

Motahareh Sadat Mirhaj Mohammadabadi (MS)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Homa Mohammadsadeghi (H)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Mehrdad Eftekhar Adrebili (M)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Zahra Partovi Kolour (Z)

Students Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Fatemeh Kashaninasab (F)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Vahid Rashedi (V)

Iranian Research Center on Aging, Department of Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.

Mohammadreza Shalbafan (M)

Mental Health Research Center, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Classifications MeSH